Board of Pharmacy public meetings in 2025

Board of Pharmacy

The Louisiana Board of Pharmacy is conducting a public hearing to solicit comments and testimony on three regulatory projects. These projects concern prescription drug delivery, dispensing, and record retention.

• Regulatory Project 2025-07: Prescription Drug Delivery
• Regulatory Project 2025-08: Centralized Prescription Dispensing
• Regulatory Project 2025-09: Prescription Monitoring Program Record Retention

Board of Pharmacy

The Louisiana Board of Pharmacy will consider its proposed budgets for fiscal years 2025-2026 and 2026-2027, as well as the legislative auditor's financial audit report. The board will also discuss multiple proposed voluntary consent agreements in disciplinary cases and several regulatory proposals, including those on controlled dangerous substances and remote access by pharmacy technicians. Public comment is invited.

• Consideration of Legislative Auditor’s Financial Audit Report for Fiscal Year 2024-2025
• Consideration of Proposed Budget Amendment No. 1 for Fiscal Year 2025-2026 (Draft #1)
• Consideration of Proposed Budget for Fiscal Year 2026-2027 (Draft #1)
• Consideration of proposed voluntary consent agreements in 8 disciplinary cases (e.g., The Compounding Center Pharmacy, EmpiRx Health)
• Regulatory proposals on controlled dangerous substances, remote access by pharmacy technicians, community pharmacy, and institutional pharmacy

The Board elected Richard M. Indovina, Jr. as President and approved the proposed budget for Fiscal Year 2026-2027. Members also approved several regulatory changes regarding controlled substances and pharmacy technician remote access. Multiple disciplinary actions and fines were issued to pharmacies and technicians.

• Elected Richard M. Indovina, Jr. as President
• Approved Proposed Budget for Fiscal Year 2026-2027, Draft #1
• Approved $250,000 for Board office building maintenance and renovations
• Approved Regulatory Proposal 2025-E allowing remote access by pharmacy technicians
• Fined The Compounding Center Pharmacy $15,000 and placed permit on probation
• Fined Independent Health Services, Inc $20,000 for dispensing with expired permit
• Fined EmpiRx Health, LLC $17,788 for providing PBM services without credentials
• Approved full PMP reporting waivers for 21 pharmacies

Board of Pharmacy

The Regulation Revision Committee will review several regulatory projects and proposals. Discussions include controlled dangerous substances, pharmacy technician remote access, and updates on a CVS Health Air Support pilot project.

• Regulatory Project 2025-10: Controlled Dangerous Substances – Draft #3
• Regulatory Proposal 2025-E: Remote Access by a Pharmacy Technician – Draft #2
• Regulatory Proposal 2025-G: Community Pharmacy – Draft #1
• Regulatory Proposal 2025-H: Institutional Pharmacy – Draft #1
• Pilot Project Update: CVS Health Air Support - Remote Product Verification

Board of Pharmacy

The Board approved four regulatory proposals concerning prescription drug delivery, centralized dispensing, PMP record retention, and controlled substances. It also issued several fines and license revocations for pharmacy and PBM credentialing violations.

• Approved Regulatory Proposal 2025-A on Prescription Drug Delivery
• Approved Regulatory Proposal 2024-K on Centralized Prescription Dispensing
• Approved Regulatory Proposal 2025-D on PMP Record Retention
• Approved Regulatory Proposal 2025-F on Controlled Dangerous Substances
• Permanently revoked credential of Bocage Pharmacy Centre, Inc
• Fined WellDyneRx, LLC $60,000 for operating as a PBM without credentials
• Fined Script Care Ltd $50,000 for operating as a PBM without credentials
• Fined True Rx Management Services, Inc $25,000 for operating as a PBM without credentials

Board of Pharmacy

The Board will consider unaudited financial statements for Fiscal Year 2024-2025 and several proposed regulatory changes. The meeting includes reviews of voluntary consent agreements for pharmacies and practitioners, as well as updates to the Policy & Procedure Manual.

• Consideration of Unaudited Compiled Financial Statements for Fiscal Year 2024-2025
• Regulatory proposals on Prescription Drug Delivery, Centralized Prescription Dispensing, PMP Record Retention, and Controlled Dangerous Substances
• Proposed voluntary consent agreements for Daniel Pharmacy, LLC, Bocage Pharmacy Centre, Inc., and others
• Review of Compliance Questionnaire for Annual Legislative Audit and the Annual Report
• Proposed revisions to Policy & Procedure Manual regarding travel budgets and record retention

Board of Pharmacy

The Louisiana Board of Pharmacy will meet on August 20, 2025, to conduct administrative hearings regarding five cases involving pharmacy professionals. The board will also take public comment and may add new agenda items during the meeting.

• Formal hearings for Lindsey Sharp Morgan (Case 24-0307), Markella Ann Wyre (Case 25-0044), Tavia Torshel Solomon (Case 25-0038), Rebecca Lynn Buchanan (Case 25-0052), and Kwanita Lathesia Thomas (Case 25-0069)
• Opportunity for public comment
• Board may add new agenda items during the meeting

Board of Pharmacy

The Board of Pharmacy is holding a public hearing to solicit comments on its rules. The body is seeking input on any rules in LAC 46:LIII. Chapters 1 through 33 that are believed to be contrary to law, outdated, unnecessary, overly complex, or burdensome.

• Regulatory Project 2025-454: Solicitation of comments on LAC 46:LIII. Chapters 1 through 33

Board of Pharmacy

The Louisiana Board of Pharmacy is soliciting public comments and testimony regarding three regulatory projects. These projects involve pharmacy technician qualifications, nonresident pharmacies, and practitioner CDS licenses.

• Regulatory Project 2025-03: Pharmacy Technician Certificate Qualifications
• Regulatory Project 2025-05: Nonresident Pharmacy
• Regulatory Project 2025-06: Practitioner CDS License

Board of Pharmacy

The Board will consider the annual renewal of various professional service contracts and the approval of updated operational manuals. Members will also review proposed voluntary consent agreements for several pharmacies and individuals.

• Annual renewal of contracts for Bamboo Health, Inc., Tyler Technologies, and Covalent Logic
• Proposed voluntary consent agreements for Parker’s Pharmacy, LLC, Smith Health, Inc., and Alius Health, LLC
• Consideration of professional legal services for Celia R. Cangelosi and Shows, Cali & Walsh, LLP
• Approval of updated Loss Prevention and Policy & Procedure manuals
• Distinguished Service Award presentation to J. Troy Menard

The Board renewed several operational contracts and professional service agreements for the 2025-2026 fiscal year. It also issued multiple disciplinary actions, including the permanent revocation of a pharmacy credential and various fines. Additionally, the Board approved PMP reporting waivers for 16 pharmacies.

• Permanently revoked credential of Parker’s Pharmacy, LLC for improper closure and illegal possession of substances
• Fined Orlando Jermaine Palmer $5,000 and restricted pharmacy ownership
• Fined Smith Health, Inc, Alius Health, LLC, and FairosRx, LLC $5,000 each for operating as PBMs without credentials
• Suspended licenses for Kevin Trenouth Kellow (10 years), Carly Kristin Bordelon (5 years), and Cody Lane Guitreau (5 years), then placed on probation
• Approved $215,000 contract with Bamboo Health, Inc. for state prescription monitoring program
• Approved $600,000 contract with Bamboo Health, Inc. for PMP Gateway contingent on grant funds
• Approved $150,000 contract with Tyler Technologies for eLicense hosting
• Approved PMP reporting waivers for 16 pharmacies

Board of Pharmacy

The Louisiana Board of Pharmacy's Reinstatement Committee will meet on May 6, 2025, to consider petitions for reinstatement of suspended, lapsed, or inactive pharmacy credentials. The agenda includes individual hearings for two reinstatement petitions and one modification of a previous order, plus dozens of applications for reinstatement of credentials lapsed for various periods. The committee may also enter executive session for discussions on personnel, litigation, security, or misconduct allegations.

• Petition for reinstatement: Quenice Nicole Bates (Case No. 25-0085) and LaDonna Natosha Mitchell (Case No. 25-0082)
• Petition for modification of previous orders: Kristian Raymond Hahn (Case No. 25-0051)
• Reinstatement of credentials lapsed >5 years: Sadia Kalim Ijaz (PST.017827)
• Discretionary approvals by committee chair for 16 applicants with credentials lapsed >1 but <5 years
• Staff approvals via board policy for 32 applicants with credentials lapsed <1 year

Board of Pharmacy

The Executive Committee of the Louisiana Board of Pharmacy will consider renewing several annual items, including the Loss Prevention Manual, Policy & Procedure Manual, rosters of approved pharmacy colleges and technician training programs, and credentialing exams. The committee will also vote on renewing contracts for legal, accounting, and technology services, as well as the Prescription Monitoring Program and licensing system. Additionally, the board may enter a closed session to discuss litigation, personnel matters, or security procedures.

• Renewal of credentialing exams: NAPLEX, MPJE, FPGEE for pharmacists; PTCE and ExCPT for technicians
• Renewal of professional legal services contracts with Celia R. Cangelosi and Shows, Cali & Walsh, LLP
• Renewal of Prescription Monitoring Program contract with Bamboo Health, Inc.
• Renewal of licensing information system contract with Tyler Technologies
• Possible closed session for litigation discussion and other exempt matters

Board of Pharmacy

The Louisiana Board of Pharmacy's Impairment Committee will meet on May 6, 2025, to consider reinstatement applications for four pharmacists and modification requests for two prior orders. The committee will also review and potentially expand its roster of approved addictionists with three new practitioners. The meeting is open to the public.

• Reinstatement applications for credentials: Kevin Trenouth Kellow, Carly Kristin Bordelon, Cody Lane Guitreau, Christi Shantelle Williams
• Petitions to modify previous orders: Scotty Paul Broussard and Patience Viator Bergeron
• Annual review of the Roster of Approved Addictionists
• Consideration of adding three new addictionists: Drs. Peter Shore Kamp (MS), Cesar Gonzales (LA), and Sarah C. Hamauei (LA)

Board of Pharmacy

The Louisiana Board of Pharmacy will meet to vote on proposed voluntary consent agreements in several disciplinary cases involving pharmacists and pharmacies, and to consider new regulations including updates to controlled dangerous substance schedules and pharmacy technician certificate qualifications. The board may also enter executive session for discussions on personnel, litigation, security, or misconduct investigations.

• Consideration of proposed voluntary consent agreements in 9 disciplinary cases (e.g., Case No. 24-0338, 24-0332, 24-0397)
• Regulatory Proposal 2025-B: Nonresident Pharmacy (Draft #1) and 2025-C: Practitioner CDS License (Draft #1)
• Proposed pilot project on remote processing services and final product verification
• Prescription Monitoring Program quarterly report and requests for PMP reporting exemptions
• NAPLEX and MPJE passing rates for 2022-2024 graduates

The Board approved a one-year pilot project for CVS Health to use remote final product verification for prescriptions. The Board also approved several regulatory updates, including CDS schedule updates and pharmacy technician qualification changes.

• Authorized one-year CVS Health remote 'final product verification' pilot (11-4)
• Approved Legislative Proposal 2025-B for CDS Schedules Update (Unanimous)
• Approved Regulatory Project 2025-03 for Pharmacy Technician Certificate Qualifications (Unanimous)
• Approved Regulatory Proposal 2025-B for Nonresident Pharmacy (Unanimous)
• Approved Regulatory Proposal 2025-C for Practitioner CDS License (Unanimous)
• Revoked credential of D’Shay Nicole Watson for alleged diversion of controlled substances (Unanimous)
• Issued $6,000 fine to Darvis Keon Harvey for improper record keeping (Unanimous)
• Granted PMP reporting waivers to 15 pharmacies (Unanimous)